title: Arsenic trioxide and mannitol for the treatment of acute promyelocytic leukemia relapse in the central nervous system.
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Hong
authors: http://orcid.org/0000-0002-4727-7010
authors: H
authors: Wang
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China Heilongjiang Institute for Hematology and Oncology Research, Harbin, China.
authors: Fenglin
authors: F
authors: Cao
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Jinmei
authors: J
authors: Li
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Limin
authors: L
authors: Li
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China Department of Hematology, Radiology Branch, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Yong
authors: Y
authors: Li
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Ce
authors: C
authors: Shi
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Wenjia
authors: W
authors: Lan
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Dandan
authors: D
authors: Li
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Hui
authors: H
authors: Zhao
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Ying
authors: Y
authors: Zhang
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Zhuo
authors: Z
authors: Zhang
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Xiuhua
authors: X
authors: Liu
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Ran
authors: R
authors: Meng
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: Baofeng
authors: B
authors: Yang
authors: Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China Heilongjiang Institute for Hematology and Oncology Research, Harbin, China.
authors: Jin
authors: J
authors: Zhou
mesh_terms: D000293:Adolescent; D000328:Adult; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage* / Q000134:cerebrospinal fluid; D001812:Blood-Brain Barrier / Q000187:drug effects; D016543:Central Nervous System Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D060828:Induction Chemotherapy; D015473:Leukemia, Promyelocytic, Acute / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008297:Male; D008353:Mannitol / Q000008:administration & dosage*; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage* / Q000134:cerebrospinal fluid; D012008:Recurrence; D012074:Remission Induction; D055815:Young Adult
chemical_list: D001152:Arsenicals; D010087:Oxides; D008353:Mannitol; D000077237:Arsenic Trioxide